Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Asthenia
ADR ID BADD_A00362
ADR Hierarchy
08      General disorders and administration site conditions
08.01      General system disorders NEC
08.01.01      Asthenic conditions
08.01.01.001      Asthenia
Description Clinical sign or symptom manifested as debility, or lack or loss of strength and energy. [MeSH]
MedDRA Code 10003549
MeSH ID D001247; D009440; D000073496
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Adynamia | Asthenia | Collapse of legs | Debility | Debility marked | Debility, unspecified | Feeling of total lack of energy | Feelings of weakness | General debility | Loss of energy | Nervous debility | Neurasthaenia | Neurasthenia | Strength loss of | Weakness | Weakness generalised | Weakness generalized | Weakness postural | Energy decreased | Frailty | Weakness worsened | Hyposthenia | Cerebro-asthenic syndrome
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01083Hydrochlorothiazide0.000263%
BADD_D01084Hydrocodone--
BADD_D01086Hydrocortisone0.000295%
BADD_D01093Hydroflumethiazide--
BADD_D01095Hydrogen iodide--
BADD_D01096Hydromorphone--
BADD_D01102Hydroxybutanoic acid--
BADD_D01103Hydroxychloroquine--
BADD_D01106Hydroxyprogesterone--
BADD_D01110Hydroxyurea--
BADD_D01111Hydroxyzine--
BADD_D01114Hyoscyamine--
BADD_D01115Hyoscyamine sulfate--
BADD_D01117Ibandronic acid--
BADD_D01118Ibritumomab tiuxetan--
BADD_D01119Ibrutinib0.012357%
BADD_D01120Ibuprofen--
BADD_D01124Icodextrin--
BADD_D01130Idelalisib--
BADD_D01133Ifosfamide--
BADD_D01134Iloperidone0.000131%
BADD_D01135Iloprost0.001760%
BADD_D01136Imatinib--
BADD_D01137Imatinib mesylate--
BADD_D01139Imipramine--
BADD_D01140Imipramine hydrochloride--
BADD_D01141Imipramine pamoate--
BADD_D01142Imiquimod0.002283%
BADD_D01149Indapamide0.003957%
BADD_D01150Indinavir--
The 20th Page    First    Pre   20 21 22 23 24    Next   Last    Total 47 Pages
ADReCS-Target
ADR Term Drug Name Target